BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

TeselaGen

TeselaGen logo

Website
http://teselagen.com/
Founded
2011

Technologies

AI Companies (Drug Discovery)

TeselaGen has developed a powerful, cloud-based and AI-driven platform for accelerating the engineering of biological systems.


Articles Mentioning This Company

AI in Synthetic Biology: From Gene Editing to Pathway Design

From Gene Editing to Pathway Design: How AI is Transforming Synthetic Biology

Oct. 22, 2025     Articles
Synthetic biology refers to the purposeful design and construction of new biological components, devices, and systems, as well as the re-engineering of existing natural biological systems to serve practical functions. It extends the principles of genetic engineering, adopting a design-driven approach that incorporates concepts such as standardization, modularity and abstraction. …

R&D Platform

Make and modify DNA. Allows researchers to: Prototype and edit recombinant molecules for vaccines and biologic medicines.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.